Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.41+0.01 (+2.18%)
Close on Nov 18, 2026Market cap $82.86MP/E –Yield –
Lucid Diagnostics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Lucid Diagnostics's operating income for the twelve months ending Jun 30, 2026 was -$50.69M. For fiscal 2025 it was -$49.64M. The highest annual figure on record is -$8.28M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.64M | – |
| FY2024 | Dec 31, 2024 | -$46.05M | – |
| FY2023 | Dec 31, 2023 | -$48.48M | – |
| FY2022 | Dec 31, 2022 | -$56.25M | – |
| FY2021 | Dec 31, 2021 | -$27.42M | – |
| FY2020 | Dec 31, 2020 | -$8.28M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.80M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.11M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.01M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.38M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.49M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.38M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.79M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.13M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.58M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.38M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.63M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.24M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.51M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.02M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.73M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.02M | – |
See a number that looks wrong?